PitchBook clients can access the full report and Excel data pack via the Research Center on the PitchBook Platform.
Healthcare PE defies broader fundraising slowdown, while life sciences VC slows
Against the backdrop of a challenging year for private market fundraising, healthcare specialist managers saw capital consolidate around fewer, larger vehicles—rewarding incumbents and squeezing out emerging players. Healthcare PE commitments reached $18.3 billion, the third-highest total on record, but the concentration was stark: Four funds accounted for 67% of commitments, while total fund count dropped 46.3% YoY.
In venture, life sciences posted its weakest fundraising year since 2019 by both total capital and new funds closed, though the specialty’s share of total VC closings held remarkably steady—despite significant headwinds for the biotech sector.
Our latest report unpacks the full GP fundraising landscape across healthcare PE, life sciences VC, and healthtech.
Table of contents
| Key takeaways | 3 |
| Introduction | 4 |
| Healthcare specialist PE fundraising trends | 5 |
| Healthcare specialist VC fundraising trends | 8 |
| Healthcare specialist performance | 12 |
| Manager lists | 14 |
| Inclusion criteria and categories | 37 |
Healthcare specialist PE funds raised $18.3 billion in 2025.